Mouse models of brain metastasis for unravelling tumour progression
Advances in Experimental Medicine and Biology, ISSN: 2214-8019, Vol: 899, Page: 231-244
2016
- 5Citations
- 29Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations5
- Citation Indexes5
- Captures29
- Readers29
- 29
Book Chapter Description
Secondary tumours in the brain account for 40% of triple negative breast cancer patients, and the percentage may be higher at the time of autopsy. The use of in vivo models allow us to recapitulate the molecular mechanisms potentially used by circulating breast tumour cells to proliferate within the brain. Metastasis is a multistep process that depends on the success of several stages including cell evasion from the primary tumour, distribution and survival within the blood stream and cerebral microvasculature, penetration of the blood-brain barrier and proliferation within the brain microenvironment. Cellular adhesion molecules are key proteins involved in all of the steps in the metastatic process. Our group has developed two different in vivo models to encompass both seeding and colonisation stages of the metastatic process: (1) haematogenous dissemination of tumour cells by direct injection into the left ventricle of the heart, and (2) direct implantation of the tumour cells into the mouse brain. This chapter describes, in detail, the practical implementation of the intracerebral model, which can be used to analyse tumour proliferation within a specificarea of the central nervous system and tumour–host cell interactions. We also describe the use of immunohistochemistry techniques to identify, at the molecular scale, tumour–host cell interactions, which may open new windows for brain metastasis therapy.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84978286902&origin=inward; http://dx.doi.org/10.1007/978-3-319-26666-4_13; http://www.ncbi.nlm.nih.gov/pubmed/27325270; http://link.springer.com/10.1007/978-3-319-26666-4_13; https://dx.doi.org/10.1007/978-3-319-26666-4_13; https://link.springer.com/chapter/10.1007/978-3-319-26666-4_13
Springer Nature
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know